Aurelia De Pauw

Aurelia De Pauw holds a master’s degree and Ph.D. in Science from the Gembloux Agro-Bio Tech, University of Liege and the University of Namur, Belgium. She has 13 years experience in preclinical and clinical research. Aurelia is the author of 10 peer-review articles in cellular metabolism and regenerative therapy. Her work in cardiac stem cell therapy was rewarded by the European Society of Cardiology, the Council on Basic Cardiovascular Science and the International Society for Heart Research. After establishing her career in basic sciences and regenerative therapy, she progressed from the laboratory bench to the bedside where she gained an even deeper appreciation of the impact of research on patients and caregivers. Aurelia has extensive experience in numerous therapeutic categories including oncology, drug addiction, endocrinology, dermatology and cardiology, from phase I to phase IV clinical trials. She’s now Vice-President of Clinical Programs and Medical Affairs at Tetra Bio-Pharma Inc., a pharmaceutical company developing cannabinoid-based drugs.